SMAD2 and cancer: Whereas only 10 μM of SB-431542 decreases the nuclear level of phosphorylated Smad2 in Colo320 cancer cells, 50 μM of TGFRI inhibitor decreased the nuclear level of phosphorylated Smad2 in HT29NRP2 cancer cells.